Geode Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.1M | Buy |
|
|||||
|
2025
Q1 | $43.5M | Sell |
|
|||||
|
2024
Q4 | $54.6M | Buy |
|
|||||
|
2024
Q3 | $46.2M | Buy |
|
|||||
|
2024
Q2 | $37.7M | Buy |
|
|||||
|
2024
Q1 | $44.6M | Buy |
|
|||||
|
2023
Q4 | $36M | Buy |
|
|||||
|
2023
Q3 | $30.1M | Buy |
|
|||||
|
2023
Q2 | $31.7M | Buy |
|
|||||
|
2023
Q1 | $37.6M | Buy |
|
|||||
|
2022
Q4 | $35.9M | Buy |
|
|||||
|
2022
Q3 | $32.1M | Buy |
|
|||||
|
2022
Q2 | $27.2M | Buy |
|
|||||
|
2022
Q1 | $30.1M | Sell |
|
|||||
|
2021
Q4 | $28M | Buy |
|
|||||
|
2021
Q3 | $25.3M | Buy |
|
|||||
|
2021
Q2 | $27.9M | Buy |
|
|||||
|
2021
Q1 | $22.8M | Buy |
|
|||||
|
2020
Q4 | $20M | Buy |
|
|||||
|
2020
Q3 | $15.9M | Sell |
|
|||||
|
2020
Q2 | $18.4M | Buy |
|
|||||
|
2020
Q1 | $13.6M | Buy |
|
|||||
|
2019
Q4 | $17M | Buy |
|
|||||
|
2019
Q3 | $19.1M | Buy |
|
|||||
|
2019
Q2 | $22.4M | Buy |
|
|||||
|
2019
Q1 | $22.2M | Buy |
|
|||||
|
2018
Q4 | $19.5M | Buy |
|
|||||
|
2018
Q3 | $27.4M | Buy |
|
|||||
|
2018
Q2 | $31.5M | Buy |
|
|||||
|
2018
Q1 | $22.9M | Buy |
|
|||||
|
2017
Q4 | $18.5M | Buy |
|
|||||
|
2017
Q3 | $18M | Sell |
|
|||||
|
2017
Q2 | $19.6M | Buy |
|
|||||
|
2017
Q1 | $14M | Buy |
|
|||||
|
2016
Q4 | $9.55M | Buy |
|
|||||
|
2016
Q3 | $8.52M | Buy |
|
|||||
|
2016
Q2 | $5.62M | Buy |
|
|||||
|
2016
Q1 | $3.6K | Sell |
|
|||||
|
2015
Q4 | $3.84M | Buy |
|
|||||
|
2015
Q3 | $3.98M | Buy |
|
|||||
|
2015
Q2 | $4.05M | Buy |
|
|||||
|
2015
Q1 | $1.86M | Buy |
|
|||||
|
2014
Q4 | $1.22M | Buy |
|
|||||
|
2014
Q3 | $1.27M | Buy |
|
|||||
|
2014
Q2 | $1.54M | Buy |
|
|||||
|
2014
Q1 | $764K | Buy |
|
|||||
|
2013
Q4 | $601K | Buy |
|
|||||
|
2013
Q3 | $444K | Buy |
|
|||||
|
2013
Q2 | $376K | Buy |
|